University of Leicester
Browse

Outcomes of vascular and endovascular interventions performed during the COVID-19 pandemic: The Vascular and Endovascular Research Network (VERN) COvid-19 Vascular sERvice (COVER) Tier 2 study

Download (607.22 kB)
journal contribution
posted on 2021-01-06, 16:04 authored by Ruth A. Benson, Sandip Nandhra, The Vascular and Endovascular Research NetworkVERN COVER Study Collaborative
<div>Objective: </div><div>The aim of the COVER Study is to identify global outcomes and decision making for vascular procedures during the pandemic.</div><div><br></div><div>Background data: </div><div>During its initial peak, there were many reports of delays to vital surgery and the release of several guidelines advising later thresholds for vascular surgical intervention for key conditions.</div><div><br></div><div>Methods: </div><div>An international multi-centre observational study of outcomes following open and endovascular interventions.</div><div><br></div><div>Results: </div><div>In an analysis of 1,103 vascular intervention (57 centres in 19 countries), 71.6% were elective or scheduled procedures. Mean age was 67 ± 14 years (75.6% male). Suspected or confirmed COVID-19 infection was documented in 4.0%. Overall, in-hospital mortality was 11.0%. (aortic interventions mortality 15.2% [23/151], amputations 12.1% [28/232], carotid interventions 10.7% [11/103], lower limb revascularisations 9.8% [51/521]). Chronic obstructive pulmonary disease (Odds ratio [OR] 2.02, 95% CI 1.30–3.15) and active lower respiratory tract infection due to any cause (OR 24.94, 95% CI 12.57–241.70) ware associated with mortality, whereas elective or scheduled cases were lower risk (OR 0.4, 95% CI 0.22–0.73 and 0.60, 95% CI 0.45–0.98 respectively. After adjustment, antiplatelet (Odds Ratio [OR] 0.503, 95% Confidence Interval [CI]:0.273 - 0.928) and oral anticoagulation (OR 0.411, 95% CI: 0.205 - 0.824) were linked to reduced risk of in-hospital mortality.</div><div><br></div><div>Conclusions: </div><div>Mortality following vascular interventions during this period was unexpectedly high. Suspected or confirmed COVID-19 cases were uncommon. Therefore an alternative cause e.g. recommendations for delayed surgery, should be considered. The vascular community must anticipate longer term implications for survival.</div>

Funding

The study has received financial grant support from the Circulation Foundation (no grant reference). The National Institute for Health Research (NIHR) has provided salary support for the co-chief investigators (reference: NIHR000359).

History

Author affiliation

Department of Cardiovascular Sciences

Version

  • AM (Accepted Manuscript)

Published in

Annals of Surgery

Publisher

Lippincott, Williams & Wilkins

issn

0003-4932

Acceptance date

2020-11-02

Copyright date

2020

Available date

2021-12-23

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC